Summit Therapeutics
SMMT
$8.68
Share price
-20.47%
Change (1 day)
407.89%
Change (1 year)
Categories
Market capitalization of Summit Therapeutics (SMMT)
Market cap: $6.09 Billion
As of June 2024 Summit Therapeutics has a market cap of $6.09 Billion. This makes Summit Therapeutics the world's 2343th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Summit Therapeutics from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $6.09 B | 233.3% |
| 2023 | $1.82 B | 113.79% |
| 2022 | $0.85 B | 225.51% |
| 2021 | $0.26 B | -32.01% |
| 2020 | $0.38 B | 259.7% |
| 2019 | $0.10 B | 468.07% |
| 2018 | $18.92 M | -88.56% |
| 2017 | $0.16 B | 57.11% |
| 2016 | $0.10 B | -25.33% |
| 2015 | $0.14 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Summit Therapeutics was reported to be:
$6.09 Billion
$6.09 Billion
$6.09 Billion
$6.09 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $12.27 B | 101.34% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.22 B | -96.33% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.20 B | -96.58% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 1.13% | 🇺🇸 USA |